{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:42:54Z","timestamp":1791499374899,"version":"4.3.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.urolonc.2024.01.025","type":"journal-article","created":{"date-parts":[[2024,2,24]],"date-time":"2024-02-24T20:14:15Z","timestamp":1708805655000},"page":"229-235","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Simulation of the effects of molecular urine markers in follow-up of patients with high-risk non-muscle invasive bladder cancer"],"prefix":"10.1016","volume":"42","author":[{"given":"Natalya","family":"Benderska-S\u00f6der","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Ecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Kleinlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Roghmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekkehardt","family":"Bismarck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bas W.G.","family":"van Rhijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnulf","family":"Stenzl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes Alfred","family":"Witjes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilman","family":"Todenh\u00f6fer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver W.","family":"Hakenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc Oliver","family":"Grimm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Goebell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Burger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorgen Bjerggaard","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4004-1857","authenticated-orcid":false,"given":"Bernd J.","family":"Schmitz-Dr\u00e4ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.urolonc.2024.01.025_bib0001","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","article-title":"European Association of urology guidelines on non-muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ)","volume":"81","author":"Babjuk","year":"2022","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2024.01.025_bib0002","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.juro.2016.06.049","article-title":"Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO guideline","volume":"196","author":"Chang","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2024.01.025_bib0003","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.juro.2014.07.015","article-title":"The risk of urinary tract infection after flexible cystoscopy in patients with bladder tumor who did not receive prophylactic antibiotics","volume":"193","author":"Herr","year":"2015","journal-title":"J Urol"},{"issue":"22","key":"10.1016\/j.urolonc.2024.01.025_bib0004","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1093\/ajhp\/zxaa270","article-title":"Evaluation of post-flexible cystoscopy urinary tract infection rates","volume":"77","author":"Cusumano","year":"2020","journal-title":"Am J Health Syst Pharm"},{"issue":"Suppl 1","key":"10.1016\/j.urolonc.2024.01.025_bib0005","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/bju.15527","article-title":"Music during flexible cystoscopy for pain and anxiety - a patient-blinded randomised control trial","volume":"128","author":"McClintock","year":"2021","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2024.01.025_bib0006","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.eururo.2015.10.024","article-title":"Economic burden of bladder cancer across the European Union","volume":"69","author":"Leal","year":"2016","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.urolonc.2024.01.025_bib0007","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/cncr.25523","article-title":"Detection and clinical outcome of urinary bladder cancer with 5-aminolevulinic acid-induced fluorescence cystoscopy: a multicenter randomized, double-blind, placebo-controlled trial","volume":"117","author":"Stenzl","year":"2011","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.urolonc.2024.01.025_bib0008","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.eururo.2013.03.059","article-title":"Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw data","volume":"64","author":"Burger","year":"2013","journal-title":"Eur Urol"},{"issue":"7","key":"10.1016\/j.urolonc.2024.01.025_bib0009","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.urolonc.2013.10.010","article-title":"Considerations on the use of urine markers in the management of patients with low-\/intermediate-risk non-muscle invasive bladder cancer","volume":"32","author":"Schmitz-Dr\u00e4ger","year":"2014","journal-title":"Urol Oncol"},{"issue":"6","key":"10.1016\/j.urolonc.2024.01.025_bib0010","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.euf.2022.02.006","article-title":"Reducing the frequency of follow-up cystoscopy in low-grade pTa Non\u2013muscle-invasive bladder cancer using the ADXBLADDER biomarker","volume":"8","author":"Roupret","year":"2022","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.urolonc.2024.01.025_bib0011","doi-asserted-by":"crossref","first-page":"77.e9","DOI":"10.1016\/j.urolonc.2020.07.013","article-title":"Prospective validation of clinical usefulness of a novel mRNAbased urine test (Xpert Bladder Cancer Monitor) for surveillance in non muscle invasive bladder cancer","volume":"39","author":"Elsawy","year":"2021","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2024.01.025_bib0012","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.urolonc.2016.06.001","article-title":"Replacing cystosopy by urine markers in the follow-up of patients with low risk non muscle-invasive bladder cancer? \u2013 An IBCN project","volume":"34","author":"Schmitz-Dr\u00e4ger","year":"2016","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2024.01.025_bib0013","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.urolonc.2020.01.006","article-title":"Towards non-invasive follow-up of low risk bladder cancer \u2013 rationale and concept of the UroFollow trial","volume":"12","author":"Benderska-S\u00f6der","year":"2020","journal-title":"Urol Oncol"},{"issue":"1","key":"10.1016\/j.urolonc.2024.01.025_bib0014","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.juro.2009.08.150","article-title":"Cystoscopy revisited as the gold standard for detecting bladder cancer recurrence: diagnostic review bias in the randomized, prospective CEFUB trial","volume":"183","author":"van der Aa","year":"2010","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.urolonc.2024.01.025_bib0015","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.eururo.2008.05.001","volume":"55","author":"van der Aa","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2024.01.025_bib0016","unstructured":"https:\/\/ichgcp.net\/clinical-trials-registry\/NCT04100733 (accessed December 10, 2022)"},{"key":"10.1016\/j.urolonc.2024.01.025_bib0017","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.eururo.2020.12.033","article-title":"European Association of Urology (EAU) prognostic factor risk groups for non-muscle-invasive bladder cancer (NMIBC) incorporating the WHO 2004\/2016 and WHO 1973 classification systems for grade: an update from the EAU NMIBC guidelines panel","volume":"79","author":"Sylvester","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2024.01.025_bib0018","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/j.juro.2009.07.016","article-title":"Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with Bacillus Calmette-Guerin: the CUETO scoring model","volume":"182","author":"Fernandez-Gomez","year":"2009","journal-title":"J Urol"},{"issue":"8","key":"10.1016\/j.urolonc.2024.01.025_bib0019","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.acuro.2019.02.006","article-title":"Validation of the CUETO scoring model for predicting recurrence and progression in T1G3 urothelial carcinoma of the bladder","volume":"43","author":"Krajewski","year":"2019","journal-title":"Actas Urol Esp (Engl Ed)"},{"key":"10.1016\/j.urolonc.2024.01.025_bib0020","author":"Grimm","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2024.01.025_bib0021","series-title":"13th Meeting of the European Multidisciplinary Congress on Urological Cancers (EMUC)","article-title":"Recurrence risk in patients with high grade non-muscle invasive bladder carcinoma in the Randomised Phase III clinical trial \u2018NIMBUS\u2019 \u2013 final results","author":"Grimm","year":"2021"},{"issue":"4","key":"10.1016\/j.urolonc.2024.01.025_bib0022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta14040","article-title":"Systematic review of the clinical effectiveness and cost-effectiveness of photodynamic diagnosis and urine biomarkers (FISH, ImmunoCyt, NMP22) and cytology for the detection and follow-up of bladder cancer","volume":"14","author":"Mowatt","year":"2010","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.urolonc.2024.01.025_bib0023","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1080\/21681805.2017.1310130","article-title":"Voided urine versus bladder washing cytology for detection of urothelial carcinoma: which is better?","volume":"51","author":"Keller","year":"2017","journal-title":"Scand J Urol"},{"issue":"6","key":"10.1016\/j.urolonc.2024.01.025_bib0024","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.euo.2021.10.003","article-title":"Diagnostic accuracy of novel urinary biomarker tests in non-muscle-invasive bladder cancer: a systematic review and network meta-analysis","volume":"4","author":"Laukhtina","year":"2021","journal-title":"Eur Urol Oncol"},{"issue":"6","key":"10.1016\/j.urolonc.2024.01.025_bib0025","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/bju.15677","article-title":"Nomograms including the UBC\u00ae Rapid test to detect primary bladder cancer based on a multicentre dataset","volume":"130","author":"Meisl","year":"2022","journal-title":"BJU Int"},{"issue":"1","key":"10.1016\/j.urolonc.2024.01.025_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2012.09.011","article-title":"Is the performance of urinary cytology as high as reported historically? A contemporary analysis in the detection and surveillance of bladder cancer","volume":"32","author":"Yafi","year":"2014","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2024.01.025_bib0027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/BLC-211602","article-title":"Commentary: sensitivity and specificity in urine bladder cancer markers \u2013 Is it that simple?","volume":"8","author":"Roghmann","year":"2022","journal-title":"Bladder Cancer"},{"issue":"6","key":"10.1016\/j.urolonc.2024.01.025_bib0028","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1245\/s10434-016-5763-5","article-title":"Anticipatory positive urine tests for bladder cancer","volume":"24","author":"Gopalakrishna","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.urolonc.2024.01.025_bib0029","doi-asserted-by":"crossref","first-page":"108.e19","DOI":"10.1016\/j.urolonc.2021.11.013","article-title":"The bladder epicheck test and cytology in the follow-up of patients with non-muscle-invasive high grade bladder carcinoma","volume":"40","author":"Pierconti","year":"2022","journal-title":"Urol Oncol"},{"issue":"4","key":"10.1016\/j.urolonc.2024.01.025_bib0030","article-title":"Narrow band imaging versus white light cystoscopy alone for transurethral resection of non-muscle invasive bladder cancer","volume":"4","author":"Lai","year":"2022","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143924000413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143924000413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,2]],"date-time":"2024-06-02T06:07:14Z","timestamp":1717308434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143924000413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S1078143924000413"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2024.01.025","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Simulation of the effects of molecular urine markers in follow-up of patients with high-risk non-muscle invasive bladder cancer","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2024.01.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}